DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • Germany
  • /
  • Materials
Author Program NEWCreate Narrative
EVK logo

Evonik Industries AG Stock Price

XTRA:EVK Community·€8.1b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 46 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

EVK Share Price Performance

€17.31
1.76 (11.32%)
​
€18.28
Fair Value
€17.31
1.76 (11.32%)
5.3% undervalued intrinsic discount
€18.28
Fair Value
Price €17.31
AnalystConsensusTarget €18.28
AnalystHighTarget €22.00
AnalystLowTarget €14.00
Wed, 19 Aug 26
Fair Value€18.28
Share Pricen/a

EVK Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value €18.28 5.3% undervalued intrinsic discount

Analyst Views Mixed as Evonik Faces Softer Outlook Amid Valuation Adjustments and Strategic Moves

0users have liked this narrative
0users have commented on this narrative
28users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value €22 21.3% undervalued intrinsic discount

Circular Economy And Decarbonization Trends Will Unlock Specialty Markets

0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value €14 23.6% overvalued intrinsic discount

Rising EU Pressure And Market Shifts Will Squeeze Margins

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
EVK logo
Evonik Industries
21.3% undervalued intrinsic discount

Circular Economy And Decarbonization Trends Will Unlock Specialty Markets

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Updated 3 Sep
Read Narrative
EVK logo
Evonik Industries
5.3% undervalued intrinsic discount

Analyst Views Mixed as Evonik Faces Softer Outlook Amid Valuation Adjustments and Strategic Moves

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 19 Aug
Read Narrative
EVK logo
Evonik Industries
23.6% overvalued intrinsic discount

Rising EU Pressure And Market Shifts Will Squeeze Margins

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 26 Jun
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystHighTarget
EVK logo

EVK: Execution On New Capacity Investments Is Expected To Support Re Rating

Fair Value: €22 21.3% undervalued intrinsic discount
4 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystConsensusTarget
EVK logo

EVK: Fair Value View Weighs Q2 EBITDA Support Against Sector Headwinds

Fair Value: €18.28 5.3% undervalued intrinsic discount
28 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystLowTarget
EVK logo

EVK: Restructuring And Polyester Exit Will Constrain Future Earnings Delivery

Fair Value: €14 23.6% overvalued intrinsic discount
2 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Adequate balance sheet average dividend payer.

3 Risks
2 Rewards
View Full Analysis

Evonik Industries AG Key Details

€14.1b

Revenue

€10.6b

Cost of Revenue

€3.5b

Gross Profit

€3.4b

Other Expenses

€121.0m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
Nov 03, 2026
0.26
25.01%
0.86%
41.4%
View Full Analysis

About EVK

Founded
1847
Employees
30356
CEO
Claus Rettig
WebsiteView website
evonik.com

Evonik Industries AG operates as a chemicals company in the Asia-Pacific, Europe, the Middle East, Africa, and the Americas. It operates through the Advanced Technologies, Custom Solutions, and Infrastructure segments. The Advanced Technologies segment provides polymers for medical applications; crosslinkers; hydrogen peroxide, a sterilizing agent for cleaning silicon wafers and a bleaching agent for the paper and textile industries; fumed and precipitated silicas and silanes for the automotive, tire, electronics, and cosmetics industries; and D-/L-methionine and lysine for animal nutrition. Its Custom Solutions segment provides additives for coatings, adhesives, sealants, polyurethane foams, and lubricants for the cosmetic, cleaning, and pharmaceutical industries. The Infrastructure segment engages in the infrastructure activities and offers butadiene, MTBE, butene-1, isononanol, and DINP for use in the plastic and packaging industries, production of rubber and fuels, and as plasticizers in the construction and automotive sectors. The company was founded in 1847 and is headquartered in Essen, Germany.

Recent EVK News & Updates

User avatar
Narrative Update • Sep 03

EVK: Execution On New Capacity Investments Is Expected To Support Re Rating

Analysts raised their fair value estimate for Evonik Industries to €22 from €21, citing recent price target increases from several banks and updated assumptions around revenue growth, profit margins and future P/E multiples. Analyst Commentary on Evonik Industries Recent research on Evonik Industries points to a more constructive tone, with several bullish analysts lifting their fair value assumptions and price targets.

Recent updates

No updates

Evonik Industries AG Competitors

BAS logo

BASF

Symbol: XTRA:BAS
Market cap: €44.4b
HEI logo

Heidelberg Materials

Symbol: XTRA:HEI
Market cap: €25.2b
1COV logo

Covestro

Symbol: DB:1COV
Market cap: €12.5b
SY1 logo

Symrise

Symbol: XTRA:SY1
Market cap: €12.2b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide